Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 2
2022 1
2024 1
2025 1
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for P. naeimifar
Your search for P. Samimifar retrieved no results
Efficacy and Safety of Oxymetazoline 1% Cream for the Treatment of Mild to Moderate Facial Rosacea.
Sajdeh F, Samadi A, Naeimifar A, Yazdanparast T, Ahmadi M, Amiri F, Kassir M, Firooz A, Nasrollahi SA. Sajdeh F, et al. J Cosmet Dermatol. 2025 Apr;24(4):e16782. doi: 10.1111/jocd.16782. J Cosmet Dermatol. 2025. PMID: 40165547 Free PMC article. Clinical Trial.
The clinician's erythema assessment (CEA) and patient's self-assessment (PSA), as well as the skin biometric parameters (transepidermal water loss, sebum, stratum corneum hydration, temperature, erythema, melanin, and pH), dermal and epidermal thickness and echo-density, and capi …
The clinician's erythema assessment (CEA) and patient's self-assessment (PSA), as well as the skin biometric parameters (transepidermal wate …
Preparation and evaluation of adapalene nanostructured lipid carriers for targeted drug delivery in acne.
Ahmad Nasrollahi S, Koohestani F, Naeimifar A, Samadi A, Vatanara A, Firooz A. Ahmad Nasrollahi S, et al. Dermatol Ther. 2021 Mar;34(2):e14777. doi: 10.1111/dth.14777. Epub 2021 Jan 24. Dermatol Ther. 2021. PMID: 33433054
The results demonstrated significant reduction in acne severity index and the number of inflammatory and noninflammatory lesions after 12 weeks of treatment (P-value .02, .04, and .01, respectively). Subjective results were confirmed with significant improvement in size an …
The results demonstrated significant reduction in acne severity index and the number of inflammatory and noninflammatory lesions after 12 we …
Fabrication and efficacy assessment of combination of brimonidine and ivermectin for treatment of papulopustular rosacea.
Pakdaman SF, Samadi A, Fattahi M, Naeimifar A, Ardehali FA, Ketabi Y, Nasrollahi SA, Firooz A. Pakdaman SF, et al. J Cosmet Dermatol. 2024 Sep;23(9):2973-2981. doi: 10.1111/jocd.16372. Epub 2024 Jun 3. J Cosmet Dermatol. 2024. PMID: 38831548
RESULTS: CEA and PSA decreased significantly from 3 to 2 after 8 weeks, respectively (p-value = 0.014 for CEA and 0.010 for PSA). deltaE and deltaL, as well as skin erythema index and TEWL improved after 8 weeks of treatment (p < 0.05). ...
RESULTS: CEA and PSA decreased significantly from 3 to 2 after 8 weeks, respectively (p-value = 0.014 for CEA and 0.010 for PSA). del …
Evaluation of tolerability and efficacy of a topical emulgel containing nanoliposomal ruxolitinib phosphate in the treatment of mild atopic dermatitis: a before-after single group pilot study.
Naeimifar A, Ahmad Nasrollahi S, Samadi A, Aryanian Z, Akbari Javar H, Rouini M, Nassiri Kashani M, Firooz A. Naeimifar A, et al. J Dermatolog Treat. 2022 Dec;33(8):3160-3164. doi: 10.1080/09546634.2022.2112138. Epub 2022 Oct 5. J Dermatolog Treat. 2022. PMID: 35943737 Free article.
RESULTS: Four weeks of treatment reduced SCORAD, itching, and burning (p = .001, .001, and .001, respectively) and increased hydration, sebum, and epidermal density (p = .001, .018, and .037, respectively). ...
RESULTS: Four weeks of treatment reduced SCORAD, itching, and burning (p = .001, .001, and .001, respectively) and increased hydratio …
Comparison of Urea-Based Compounding Moisturizers and Similar Commercial Products on Skin Barrier Function: A Randomized Biometric Study.
Samadi A, Naeimifar A, Ahmad Nasrollahi S, Firooz A. Samadi A, et al. J Cosmet Sci. 2021 Mar-Apr;72(2):201-213. J Cosmet Sci. 2021. PMID: 35361325 Clinical Trial.
However, commercial products led to better improvement in TEWL, 4 h after single application in both groups (p-value = 0.04). In case of 10% urea base formulation, the rate of increase in skin hydration was also signifi cantly higher for a commercial emollient than a compo …
However, commercial products led to better improvement in TEWL, 4 h after single application in both groups (p-value = 0.04). In case …
Preparation and Optimization of Voriconazole Gel 0.25% for Topical Delivery in Terbinafine Resistance Dermatophytosis: In Vitro and Pilot Animal Study.
Nasrollahi SA, Fattahi M, Lotfali E, Naeimifar A, Amiri F, Ghaderi A, Tamimi P, Zamani S, Khamesipoor A, Firooz A. Nasrollahi SA, et al. Dermatol Res Pract. 2026 Apr 21;2026:5995621. doi: 10.1155/drp/5995621. eCollection 2026. Dermatol Res Pract. 2026. PMID: 42027906 Free PMC article.

The VCZ 0.25% gel was proved to be an effective treatment in a time-dependent base, in comparison with terbinafine (1%) as a positive control (p < 0.05). Furthermore, using gel base VCZ 0.25% reduced the period of full treatment of A. benhamiae infection to five days, c

…
The VCZ 0.25% gel was proved to be an effective treatment in a time-dependent base, in comparison with terbinafine (1%) as a positive contro …